The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice-Reference-Cited by-同舟云学术

The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic mice

Published:2010-02-17 Issue:1 Volume:87 Page:73-82
ISSN:1755-3245
Container-title:Cardiovascular Research
language:en
Short-container-title:

Author:

Colussi Claudia,Berni Roberta,Rosati Jessica,Straino Stefania,Vitale Serena,Spallotta Francesco,Baruffi Silvana,Bocchi Leonardo,Delucchi Francesca,Rossi Stefano,Savi Monia,Rotili Dante,Quaini Federico,Macchi Emilio,Stilli Donatella,Musso Ezio,Mai Antonello,Gaetano Carlo,Capogrossi Maurizio C.

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://academic.oup.com/cardiovascres/article-pdf/87/1/73/17199338/cvq035.pdf

Reference29 articles.

1. The heart in human dystrophinopathies;Finsterer;Cardiology,2003

2. The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy;Yanagisawa;Am Heart J,1992

3. Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin;Gavillet;Circ Res,2006

4. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43;Gutstein;Circ Res,2001

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy;Metabolites;2023-08-09

2. The intercalated disc: a unique organelle for electromechanical synchrony in cardiomyocytes;Physiological Reviews;2023-07-01

3. Chinese herbal medicine for the treatment of cardiovascular diseases ─ Targeting cardiac ion channels;Pharmacological Research;2023-06

4. Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies;International Journal of Molecular Sciences;2023-02-21

5. Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development;Cardiovascular Research;2022-08-25